In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Has the Real MIS Revolution Finally Arrived?

Executive Summary

Robotics, or computer-enhanced surgery, still has its skeptics. But a small group of start-up device companies are pushing forward, claiming that they represent a radically new--and better--way to do surgery. The dilemma for the small companies: to sell the concept behind robotics while, at the same time, competitively positioning their individual offerings.

You may also be interested in...



Intuitive Surgical and Computer Motion Merge to Create Concentrated Robotics Play

Tired of fighting each other in court, the two leading robotics companies have decided to render their IP differences moot through a merger.

New EU Approvals

The Pink Sheet's list of EU centralized approvals of new active substances has been updated to include two new products, including Sanofi's Sarclisa for treating adults with relapsed and refractory multiple myeloma The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).

Coronavirus Update: After 'Warp Speed' Snub, Novavax Awarded US Military Vaccine Deal

Progress for two US-based companies in the race to develop a COVID-19 vaccine.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL1131839

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel